FDA Grants Marketing Authorization for First Diagnostic Test for Detecting Zika IgM Antibodies to InBios

InBios announces FDA clearance of its Dengue NS1 ELISA kit

InBios announces FDA emergency use authorization for its Zika ELISA

As Zika Virus Spreads, Gaps In Diagnostic Testing Present Opportunities For Drug Companies

UTMB researchers help discover simple, affordable diagnostic kit for chikungunya

Leishmania Rapid Diagnostic Device Receives FDA Clearance

FDA Clearance: CL Detect™ Rapid Test Read US Army Medical Research and Material Command Press Release...

USDA Licenses InBios' West Nile ELISA for Equine Read the press release

New Dengue IgM ELISA Study Read the article

InBios Keeps Pace With West Nile Outbreak Read the article...